Structural Heart Occluders Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Summary
GlobalData's Medical Devices sector report, “Structural Heart Occluders Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Structural Heart Occluders pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Structural heart occluders are used for treatment congenital heart defects by closing openings in the heart. Structural heart occluders covers left atrial appendage closure devices, atrial septal defect occluders, ventricular septal defect occluders, patent foramen ovale closure devices, patent ductus arteriosus closure devices.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Structural Heart Occluders under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Structural Heart Occluders and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Structural Heart Occluders under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Structural Heart Occluders Overview
4 Products under Development
4.1 Structural Heart Occluders - Pipeline Products by Stage of Development
4.2 Structural Heart Occluders - Pipeline Products by Segment
4.3 Structural Heart Occluders - Pipeline Products by Territory
4.4 Structural Heart Occluders - Pipeline Products by Regulatory Path
4.5 Structural Heart Occluders - Pipeline Products by Estimated Approval Date
Table 7: Structural Heart Occluders Companies - Pipeline Products by Stage of Development
Table 8: Structural Heart Occluders – Companies Pipeline Products by Stage of Development
Table 9: Abbott Japan Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 10: AMJ-505 Left Atrial Appendage Occlusion System - Product Status
Table 11: AMJ-505 Left Atrial Appendage Occlusion System - Product Description
Table 12: Aegis Medical Innovations Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Aegis Sierra Ligation System - Product Status
Table 14: Aegis Sierra Ligation System - Product Description
Table 15: Aegis Medical Innovations Inc. - Ongoing Clinical Trials Overview
Table 16: Aegis Sierra Ligation System - A Single-arm, Open Label, Multi-center Feasibility Study of the Aegis Sierra Ligation System in Left Atrial Appendage Closure in Patients with Atrial Fibrillation
Table 26: atHeart Medical - Ongoing Clinical Trials Overview
Table 27: reSept ASD Occluder - Evaluation of the Safety and Efficacy of the reSept ASD Occluder to Treat Patients with Clinically Significant Secundum Atrial Septal Defect
Table 39: CARAG AG - Ongoing Clinical Trials Overview
Table 40: Carag BioResorbable Septal Occluder - Multi Centre, International, Post Market Registry to Monitor the Clinical Performance and Safety of an Atrial Septal Closure Device with Bioresorbable Framework in Patients with Clinically Significant Atrial Septum Defect (ASD) or Patent Foramen Ovale (PFO) in Routine Clinical Use
Table 47: Conformal Medical Inc - Ongoing Clinical Trials Overview
Table 48: CLAAS Device - An Evaluation of the Safety and Effectiveness of the Conformal CLAAS System for Left Atrial Appendage Occlusion
Table 49: CLAAS Device - The CONFORMAL Early Feasibility Study an Evaluation of the Safety and Performance of the Conformal Left Atrial Appendage Seal for Left Atrial Appendage Occlusion
Table 50: CLAAS Device - The Conformal Prague Study: An Evaluation of the Safety and Performance of the Conformal Left Atrial Appendage Seal for Left Atrial Appendage Occlusion
Table 51: CLAAS Device - The Conscious Sedation Single Arm Sub-Study
Table 59: PFO Closure Device - Effectivity and Safety of PFO Closure Vs Medicine in Alleviating Migraine (SPRING): A Multicenter, Random, Case Control Study
Table 71: Guangdong Pulse Medical Technology Co Ltd - Ongoing Clinical Trials Overview
Table 72: Patent Foramen Ovale (PFO) Occluder - Prospective, Multicenter, Single-Group Target Value Method To Evaluate the Safety and Effectiveness of Patent Foramen Ovale Occluder System
Table 73: Hangzhou Dinova EP Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 74: Snowy PFO Closure System - Product Status
Table 75: Snowy PFO Closure System - Product Description
Table 76: Hangzhou Dinova EP Technology Co Ltd - Ongoing Clinical Trials Overview
Table 77: Snowy PFO Closure System - A Prospective, Multicenter, Randomized Controlled Clinical Study on the Safety and Effectiveness of the Snowy PFO Closure System in Plugging Patent Foramen Ovale
Table 92: Laminar Left Atrial Appendage Closure System - A European Trial Evaluating the Safety and Effectiveness of the Laminar Left Atrial Appendage Closure System in Subjects with Non-Valvular Atrial Fibrillation
Table 93: Laminar Left Atrial Appendage Closure System - A Trial Evaluating the Safety and Effectiveness of the Laminar Left Atrial Appendage Closure System in Subjects with Non- Valvular Atrial Fibrillation
Table 94: Laminar Left Atrial Appendage Closure System - An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects with Non-Valvular Atrial Fibrillation
Table 95: Lepu Scientech Medical Technology (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 96: LAA Closure Occluder II - Product Status
Table 97: LAA Closure Occluder II - Product Description
Table 98: MemoSorb ASD Occluder IV - Product Status 5
Table 99: MemoSorb ASD Occluder IV - Product Description 5
Table 100: MemoSorb PFO Occluder II - Product Status
Table 101: MemoSorb PFO Occluder II - Product Description
Table 106: LAmbre LAA Closure System - Can the Lambre Device Occlude IRRegular And Large Appendages in Patients With Non-Valvular AF: The CORRAL-AF Study
Table 107: LAmbre LAA Closure System - LAmbre Versus AMPLATZER Amulet Left Atrial Appendage Occluder for Stroke Prophylaxis: The Randomized AMPIRI Trial
Table 108: LAmbre LAA Closure System - LifeTech LAmbre Keft Atrial Appendage (LAA) Closure System Post-market Clinical Follow-up
Table 109: LAmbre LAA Closure System - Lifetech LAmbre Left Atrial Appendage Closure System Post-Market Clinical Follow-up Multi-center, Single-arm, Prospective, Post-market study
Table 110: LAmbre LAA Closure System - Lifetech Lambre Left Atrial Appendage Closure System Post-market Registry Single-center, Single-arm, Prospective, Post-market Registry
Table 111: LAmbre LAA Closure System - Safety and Efficacy Study of LAmbre Plus LAA occluder System in Non-valvular Atrial Fibrillation Patients
Table 134: Occlutech International AB - Ongoing Clinical Trials Overview
Table 135: Occlutech Figulla Flex II ASD Occluder - Comparative Effectiveness of Three Devices for Transcatheter Closure of Atrial Septal Defects for Adults: A Pilot Study (Trio-ASD)
Table 136: Occlutech Figulla Flex II ASD Occluder - MitraClip and Hemodynamic Effects of Relevant Iatrogenic Atrial Septum Defect Closure - Evaluation of Morphologic and Functional Changes in a Randomized Setting
Table 137: Occlutech Figulla Flex II ASD Occluder - Study to Evaluate the Efficacy of Occlutech ASD Occluder in the Treatment of Atrial Septal Defects
Table 138: Occlutech Pistol Pusher - A Registry-based, Multicenter, International, Post Market Follow-up Study to Monitor the Safety, Performance and Usability of Occlutech Accessory Medical Devices:Occlutech Delivery Set (ODS), Occlutech Pistol Pusher (OPP), Occlutech Occlusions-Pusher (OOP), Occlutech Sizing Balloon (OSB) Used During to Implantation Procedures of Cardiac Implant Devices
Table 145: LARIAT Suture Delivery Device - Adjunctive Therapy - Left Atrial Appendage Ligation with the LARIAT Suture Delivery System as Adjunctive Therapy to Pulmonary Vein Isolation for Persistent or Longstanding Persistent Atrial Fibrillation 5
Table 146: LARIAT Suture Delivery Device - Adjunctive Therapy - Non-randomized, Multicenter Expanded Use Evaluation of the LARIAT Suture Delivery Device (Appendix 16 to Ongoing Investigation) 5